Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1990; 16:424-429
© 1990 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scognamiglio, R
Right arrow Articles by Dalla-Volta, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scognamiglio, R
Right arrow Articles by Dalla-Volta, S

Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation

R Scognamiglio, G Fasoli, A Ponchia, and S Dalla-Volta

Department of Cardiology, Medical School, University of Padua, Italy.

Vasodilating agents acutely reduce regurgitant volume and improve left ventricular performance in aortic regurgitation, but more information is necessary about their long-term efficacy. To evaluate the effects of 12 months of therapy with nifedipine, a randomized, double-blind, placebo-controlled trial was performed in 72 asymptomatic patients with severe aortic regurgitation. At 12 months, patients receiving nifedipine had a significant reduction in left ventricular end-diastolic volume index (110 +/- 19 versus 136 +/- 22 ml/m2, p less than 0.01) and mass (115 +/- 19 versus 142 +/- 16 g/m2, p less than 0.01) measured by two-dimensional echocardiography. They also had a reduction in left ventricular mean wall stress (360 +/- 27 versus 479 +/- 36 kdyne/cm2, p less than 0.001) and an increase in ejection fraction (72 +/- 8% versus 60 +/- 6%, p less than 0.05). These data show that the long-term unloading action of nifedipine is able to reverse left ventricular dilation and hypertrophy and suggest that such therapy has the potential to delay the need for valve replacement in asymptomatic patients.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. H. J. Elder, L. Wei, B. R. Szwejkowski, R. Libianto, A. Nadir, M. Pauriah, S. Rekhraj, T. K. Lim, J. George, A. Doney, et al.
The Impact of Renin-Angiotensin-Aldosterone System Blockade on Heart Failure Outcomes and Mortality in Patients Identified to Have Aortic Regurgitation: A Large Population Cohort Study
J. Am. Coll. Cardiol., November 8, 2011; 58(20): 2084 - 2091.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
T. Onishi, H. Kawai, K. Tatsumi, T. Kataoka, D. Sugiyama, H. Tanaka, Y. Okita, and K.-i. Hirata
Preoperative Systolic Strain Rate Predicts Postoperative Left Ventricular Dysfunction in Patients With Chronic Aortic Regurgitation
Circ Cardiovasc Imaging, March 1, 2010; 3(2): 134 - 141.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
CirculationHome page
R. Bekeredjian and P. A. Grayburn
Valvular Heart Disease: Aortic Regurgitation
Circulation, July 5, 2005; 112(1): 125 - 134.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Y J Kim, M Jones, T Shiota, H Tsujino, J X Qin, F Bauer, M Sitges, J Kwan, L A Cardon, A D Zetts, et al.
Effect of load alterations on the effective regurgitant orifice area in chronic aortic regurgitation
Heart, October 1, 2002; 88(4): 397 - 400.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N A Boon and P Bloomfield
The medical management of valvar heart disease
Heart, April 1, 2002; 87(4): 395 - 400.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Mori, M. Nakazawa, H. Tomimatsu, and K. Momma
Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
NIFEDIPINE MAY PROTECT LEFT VENTRICLE IN AORTIC REGURGITATION
Journal Watch (General), August 14, 1990; 1990(814): 2 - 2.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement